Your browser doesn't support javascript.
Knowledge, Attitudes, and Practices of Adult Iraqi Population Towards COVID-19 Booster Dose: A Cross-Sectional Study.
Al-Qerem, Walid; Jarab, Anan; Hammad, Alaa; Alsajri, Alaa Hussein; Al-Hishma, Shadan Waleed; Ling, Jonathan; Alabdullah, Asal Saad; Salama, Ali; Mosleh, Rami.
  • Al-Qerem W; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
  • Jarab A; Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology, Irbid, Jordan.
  • Hammad A; Department of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
  • Alsajri AH; Specialized Bone Marrow Transplant Center, Baghdad, Iraq.
  • Al-Hishma SW; University of Sains Malaysia, School of Pharmaceutical Sciences, Penang, Malaysia.
  • Ling J; Specialized Bone Marrow Transplant Center, Baghdad, Iraq.
  • Alabdullah AS; Department of Pharmacy, Faculty of Science and Wellbeing University of Sunderland, Sunderland, UK.
  • Salama A; Faculty of Pharmacy, University of Jordan, Amman, Jordan.
  • Mosleh R; Department of Pharmacy, Faculty of Pharmacy, Middle East University, Amman, Jordan.
Patient Prefer Adherence ; 16: 1525-1537, 2022.
Article in English | MEDLINE | ID: covidwho-1910799
ABSTRACT

Purpose:

COVID-19 vaccines are critical for containing the pandemic and preventing serious SARS-CoV-2 infections. In addition to the two main doses, a booster dose has been utilized to improve immunity. The aim of current study is to evaluate Iraqi adult population knowledge, attitudes, and practices towards COVID-19 booster dose. Subjects and

Methods:

This online cross-sectional survey of adult Iraqis (n = 754) assessed the attitudes of people who have had both immunizations regarding a potential COVID-19 vaccine booster dosage and to identify potential factors that might impact these attitudes. Factors evaluated in the current study included previously received vaccine type in the first two doses, socioeconomic characteristics, health status, knowledge about COVID-19 and its vaccines and adherence to protective practices.

Results:

Overall, 61.1% of participants expressed willingness to receive a COVID-19 booster dose, with a high median score of knowledge and practice toward COVID-19. Participants who did not perceive COVID-19 to be serious, p-value <0.001), participants who believed they would not be infected with COVID-19 in the next 6 months (p-value <0.001), low knowledge score group (p-value <0.001), lower education (p-value <0.001), participants who received the COVID-19 vaccine because of imposed laws (p-value <0.001), participants who received AstraZeneca vaccine (p-value <0.001), younger participants (p-value=0.003), low level of practice (p-value <0.001), participants who did not know someone who had died due to COVID-19 (p-value=0.01), low risk of developing serious side effects if infected with COVID-19 and participants in the low side effects score were significantly less frequently willing to receive a booster COVID-19 dose (p-value <0.001). The main reasons for booster dose hesitancy/refusal were the perceived lack of need for a booster shot, the uselessness of a booster shot and the conspiracy theory of boosting corporate profits through booster shots.

Conclusion:

There is high hesitancy towards COVID-19 booster dose acceptance among the Iraqi population. The study identified several factors associated with vaccine hesitancy including low socioeconomic status and low knowledge about COVID-19 and its vaccines.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Patient Prefer Adherence Year: 2022 Document Type: Article Affiliation country: PPA.S370124

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Language: English Journal: Patient Prefer Adherence Year: 2022 Document Type: Article Affiliation country: PPA.S370124